The Knotty Problem of Bringing Regenerative Medicine to Market
By Alvin Powell, Harvard Staff Writer
The field of regenerative medicine is poised to break out, generating treatments and cures for a host of ailments and becoming the foundation for a new branch of biomedical industry. Harvard Office of Technology Development’s FUSION symposium brought science and business leaders together to discuss both scientific progress in regenerative medicine and the critical process of getting scientific advances out of the lab and into patients’ hospital rooms.
